Krsnaa Diagnostics (KRSNAA) | Stock Overview & Key Data
Krsnaa Diagnostics Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,099.70 on August 16, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Krsnaa Diagnostics
KRSNAA
|
19.83B Small-cap | 0.61% | -7.81% | -10.16% | -28.11% | -27.24% | -21.15% | -7.70% | -42.36% | -42.36% | -42.36% | -42.36% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | 4.53% | 0.82% | 20.51% | 13.04% | 7.03% | 8.45% | 58.06% | 0.84% | 257.00% | 257.46% | 257.46% |
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | 1.11% | 10.73% | 23.70% | 32.85% | 34.17% | 58.19% | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
|
Vimta Labs
VIMTALABS
|
20.49B Small-cap | 3.62% | 21.20% | 32.32% | -10.43% | -9.23% | 7.98% | 167.33% | 353.31% | 1,474.04% | 3,502.92% | 522.03% |
|
Suraksha Diagnostic
SURAKSHA
|
14.71B Small-cap | -2.70% | -12.26% | 6.83% | -5.81% | -1.79% | -18.17% | -35.76% | -35.76% | -35.76% | -35.76% | -35.76% |
|
Qualitek Labs
QLL
|
3.59B Small-cap | 0.22% | 15.46% | 32.25% | 2.48% | 4.30% | 43.88% | 141.56% | 141.56% | 141.56% | 141.56% | 141.56% |
Ownership & Short Interest
Calculate Your Krsnaa Diagnostics Investment Returns
Long-Term Investment Performance Analysis
Krsnaa Diagnostics stock price in Aug 2021 was ₹926.90, A ₹1,000.00 lump sum investment in Krsnaa Diagnostics made 4 years ago would be worth approximately ₹581.24 today, representing a negative return of -41.88%. This translates to an annualized return (CAGR) of -10.63%.
4 Years 9 Months Investment Scenario (Aug 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is KRSNAA's 52-week high and low?
- In the last 52 weeks, Krsnaa Diagnostics reached a high of ₹894.40 (on September 24, 2025) and a low of ₹515.00 (on March 30, 2026).
- What is the market cap and P/E ratio for KRSNAA?
- Curious about Krsnaa Diagnostics's size and valuation? Its market capitalization stands at 19.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.69, and the forward P/E (looking ahead) is 14.79.
- Does KRSNAA pay dividends? If so, what's the yield?
- Yes, Krsnaa Diagnostics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.62%, and the company has paid an average of ₹3.50 per share annually over the past 3 years.
- Who are Krsnaa Diagnostics's main competitors or similar companies to consider before investing?
When looking at Krsnaa Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 8.45% 58.06% Sai Life Sciences
SAILIFE217.06B Healthcare Diagnostics & Research 58.19% 73.11% Vimta Labs
VIMTALABS20.49B Healthcare Diagnostics & Research 7.98% 167.33% Suraksha Diagnostic
SURAKSHA14.71B Healthcare Diagnostics & Research -18.17% -35.76% Qualitek Labs
QLL3.59B Healthcare Diagnostics & Research 43.88% 141.56% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Krsnaa Diagnostics Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Krsnaa Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.79%, the Debt to Equity ratio from the most recent quarter is 30.96, and its Gross Profit Margin stands at 70.12%.
- What is the recent revenue and earnings growth for KRSNAA?
- Looking at Krsnaa Diagnostics's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.80%, and quarterly earnings saw a YoY growth of -21.50%.
- How much of KRSNAA stock is held by insiders and institutions?
- Wondering who owns Krsnaa Diagnostics stock? Company insiders (like executives and directors) hold about 44.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.97%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.